These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37091033)

  • 1. Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer.
    Lantz A; Nordlund P; Falagario U; Jäderling F; Özbek O; Clements M; Discacciati A; Grönberg H; Eklund M; Stricker P; Emberton M; Aly M; Nordström T
    Eur Urol Open Sci; 2023 May; 51():89-94. PubMed ID: 37091033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
    Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
    BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy.
    Scheltema MJ; Chang JI; Böhm M; van den Bos W; Blazevski A; Gielchinsky I; Kalsbeek AMF; van Leeuwen PJ; Nguyen TV; de Reijke TM; Siriwardana AR; Thompson JE; de la Rosette JJ; Stricker PD
    World J Urol; 2018 Sep; 36(9):1383-1389. PubMed ID: 29594551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes.
    Collettini F; Enders J; Stephan C; Fischer T; Baur ADJ; Penzkofer T; Busch J; Hamm B; Gebauer B
    Radiology; 2019 Jul; 292(1):250-257. PubMed ID: 31161973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE).
    Diven M; Ballman K; Marciscano A; Barbieri C; Piscopo J; Wang S; Nagar H; McClure T
    BMC Urol; 2024 Jul; 24(1):151. PubMed ID: 39054460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study.
    Yaxley WJ; Gianduzzo T; Kua B; Oxford R; Yaxley JW
    Investig Clin Urol; 2022 May; 63(3):285-293. PubMed ID: 35534217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT).
    Valerio M; Dickinson L; Ali A; Ramachandran N; Donaldson I; Freeman A; Ahmed HU; Emberton M
    Contemp Clin Trials; 2014 Sep; 39(1):57-65. PubMed ID: 25072507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
    van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
    Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2017 Nov; 120 Suppl 3():51-58. PubMed ID: 28834167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Description of Surgical Technique and Oncologic and Functional Outcomes of the Precision Prostatectomy Procedure (IDEAL Stage 1-2b Study).
    Sood A; Jeong W; Palma-Zamora I; Abdollah F; Butaney M; Corsi N; Wurst H; Arora S; Kachroo N; Hassan O; Gupta N; Gorin MA; Menon M
    Eur Urol; 2022 Apr; 81(4):396-406. PubMed ID: 34872786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
    Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
    Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments.
    Guenther E; Klein N; Zapf S; Weil S; Schlosser C; Rubinsky B; Stehling MK
    PLoS One; 2019; 14(4):e0215093. PubMed ID: 30986263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
    Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
    Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal irreversible electroporation as primary treatment for localized prostate cancer.
    van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2018 May; 121(5):716-724. PubMed ID: 28796935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol.
    He BM; Xue W; Yan WG; Yin L; Dong BJ; Zhou ZE; Lin HZ; Zhou Y; Wang YQ; Shi ZK; Zhou H; Wang SD; Ren SC; Gao X; Wang LH; Xu CL; Wang HF
    Front Oncol; 2021; 11():760003. PubMed ID: 34858837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SAFE Pilot Trial-SAlvage Focal Irreversible Electroporation-For Recurrent Localized Prostate Cancer: Rationale and Study Protocol.
    Marra G; Shah TT; D'Agate D; Marquis A; Calleris G; Lunelli L; Filippini C; Oderda M; Gatti M; Valerio M; Sanchez-Salas R; Bossi A; Gomez-Rivas J; Conte F; Deandreis D; Cussenot O; Ricardi U; Gontero P
    Front Surg; 2022; 9():900528. PubMed ID: 35747441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.
    Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD
    Eur Urol Focus; 2019 Jul; 5(4):585-591. PubMed ID: 29102671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.
    Blazevski A; Gondoputro W; Scheltema MJ; Amin A; Geboers B; Barreto D; Haynes AM; Shnier R; Delprado W; Agrawal S; Thompson JE; Stricker PD
    BMC Urol; 2022 Mar; 22(1):28. PubMed ID: 35236338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control.
    Ting F; Tran M; Böhm M; Siriwardana A; Van Leeuwen PJ; Haynes AM; Delprado W; Shnier R; Stricker PD
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):46-52. PubMed ID: 26458959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.